Loading...

Loading...

Global Trials Will Test AI-Engineered Antibody for Severe Asthma
By MBN Staff - Mon, 12/01/2025 - 17:37
Therapeutics company Generate:Biomedicines will begin global Phase 3 trials of GB-0895, an AI-designed antibody for severe asthma.

Partnership Content

Cluster Automotriz Nuevo Leon
https://mexicobusiness.news/tag/monoclonal-antibodies
More Health
Pembrolizumab Shows 90% Success in Rare Melanoma Trial
By Aura Moreno - Mon, 08/18/2025 - 16:57
A UCLA trial finds pembrolizumab shrinks or eliminates tumors in 90% of desmoplastic melanoma patients.
Dräger’s Atlan A350 Series Gains US DoD Security Certification
By MBN Staff - Wed, 08/13/2025 - 10:08
Dräger’s Atlan A350 anesthesia workstation series earns US DoD cybersecurity certification, securing patient data in operating rooms.
Novartis Reports Positive Phase III Results for Sjögren’s Drug
By MBN Staff - Wed, 08/13/2025 - 09:02
Novartis reports Phase III success for ianalumab, a potential first targeted treatment for Sjögren’s disease.
The Next Leap in Personalized Cancer Care
By - Tue, 03/11/2025 - 08:30
From monoclonal antibodies to the evolution toward Antibody Drug Conjugates, Luis Alberto Velez looks at the future of cancer care.

Nipocalimab Data Shows Promise for IgG-driven Diseases: J&J
By MBN Staff - Mon, 02/17/2025 - 08:00
Johnson & Johnson’s new data on nipocalimab shows its high-affinity binding, supporting its potential for IgG-driven alloantibody diseases

Tumor Molecular Profiling: A New Era for Cancer Care in Mexico
By Luis Alberto Velez - Fri, 12/20/2024 - 12:00
Luis Velez Pineda delves into the heart of tumor molecular profiling and its promise for patients worldwide, especially in Mexico.